HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 369 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCHRODER INVESTMENT MANAGEMENT GROUP | 17,952 | $647,529 | 0.00% |
| COMMONWEALTH EQUITY SERVICES, LLC | 15,869 | $572 | 0.00% |
| Creative Planning | 13,470 | $485,863 | 0.00% |
| Allianz Asset Management GmbH | 23,037 | $830,945 | 0.00% |
| WELLINGTON MANAGEMENT GROUP LLP | 126,773 | $4,572,702 | 0.00% |
| GROUP ONE TRADING, L.P. | 5,156 | $185,977 | 0.00% |
| PRIVATE TRUST CO NA | 163 | $5,879 | 0.00% |
| CarsonAllaria Wealth Management, Ltd. | 38 | $1,371 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 117,410 | $4,234,979 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 93,600 | $3,376,152 | 0.00% |
| HighTower Advisors, LLC | 18,405 | $668,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 135,600 | $4,891,092 | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 7,218 | $260 | 0.00% |
| MACKENZIE FINANCIAL CORP | 10,223 | $377,024 | 0.00% |
| BROWN ADVISORY INC | 20,811 | $750,653 | 0.00% |
| Concord Wealth Partners | 66 | $2,381 | 0.00% |
| Citadel Advisors | 13,400 | $483,338 | 0.00% |
| Citadel Advisors | 31,000 | $1,118,170 | 0.00% |
| Farther Finance Advisors, LLC | 30 | $1,082 | 0.00% |
| Daiwa Securities Group Inc. | 474 | $17 | 0.00% |
External links
This page lists HALOZYME THERAPEUTICS INC's shareholders in Q2 2023. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.